Project Grant HT94252510996
Award Date 11/1/25
Completion Date 10/31/27
Dollars Obligated $320K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Detroit, MI 48202, USA
Similar Awards
- This $924,000 Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research at Wayne State University to target dual-specificity phosphatase 1 in platinum resistance in ovarian cancer. The award, which runs from July 1, 2024 to June 30, 2028, will enable Wayne State to conduct innovative scientific studies to improve treatment options and outcomes for this challenging form of cancer, which disproportionately impacts...
- The U.S. Department of Defense's Defense Health Agency awarded a $693,000 Project Grant to Wayne State University in Detroit, Michigan under the Military Medical Research and Development program (CFDA 12.420). The grant supports the university's "EPIGENETIC THERAPEUTIC TARGETING OF ENHANCER HUBS FOR BREAST CANCER" research project, which aims to develop new treatments for breast cancer. The 3-year award, running from December 15, 2023 to December 14, 2026, will fund basic,...
- This Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) provides $400,400 to Wayne State University in Detroit, MI to conduct research on "Harnessing Immunometabolism to Ameliorate the Pathology of Ocular Chemical Injuries". The project aims to transform healthcare for military service members and the broader public by advancing innovative biomedical research on addressing medical challenges relevant to the military. The...
- This $1,844,306 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) supports research by the University of Michigan to cotarget the NSD1/2 paralogs in androgen receptor (AR)-driven castration-resistant prostate cancer. The research aims to transform healthcare for military service members, veterans, and the public by developing innovative medical solutions to address critical health challenges. The project will run...
- This $320,000.00 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research by the Regents of the University of Michigan to investigate the impact of the integrated stress response on visual synaptic circuits in multiple sclerosis. The research, to be conducted from September 1, 2025 to August 31, 2027, aims to advance the understanding of disease mechanisms and develop potential therapeutic solutions for this...
- Wayne State University was awarded a $1,386,000 Project Grant from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420). The grant will fund a novel strategy targeting the metabolic vulnerability of castration-resistant prostate cancer (CRPC) from July 1, 2023 to June 30, 2026. Through this award, Wayne State University researchers will investigate medical solutions for prostate cancer by developing and applying an innovative approach focused on CRPC's...
- This Project Grant award of $320,165.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports biomedical research at The Johns Hopkins University focused on the social determinants of health, biological aging, and disease course in multiple sclerosis. The project aims to transform healthcare for military service members, veterans, and the broader public by investigating innovative medical solutions to critical health challenges. As a leading...
- This Project Grant award of $447,625.00 was provided by the Defense Health Agency, under the Military Medical Research and Development program (CFDA 12.420), to The Washington University located in University City, Missouri. The grant supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public, with a focus on developing innovative medical solutions that address critical health challenges. The research will be conducted at...
- This $2,477,715.00 Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program will support research conducted by the Regents of the University of Michigan to develop an exoskeleton control system using a muscle cuff regenerative peripheral nerve interface (MC-RPNI) for restoring lower limb function following traumatic musculoskeletal injury. The research aims to transform healthcare for military service members and the broader...
- The University of Michigan will receive $780,000 from the Department of the Army Medical Command under the Military Medical Research and Development federal grant program to conduct a mixed-methods study from September 2021 through August 2024. The study will examine the risk of Alzheimer's disease and related dementias among people with spinal cord injuries, comparing veterans and civilians. Through supporting innovative medical research, the Military Medical Research and Development program...